Delivery Order SPE2DB25D9305-SPE2DB25FQACK

Award Date 1/30/25
Potential Completion Date 2/21/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,158 contract is for the delivery of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through December 19, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,315.80 with a firm fixed-price pricing type and a period of performance through February 24, 2025. The contract covers the delivery of MITOSOL 0.7 MG KITS, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a ceiling value of $1,315.80 and a period of performance through March 21, 2025. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,316.00 firm fixed-price contract is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through March 19, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,947.40 contract is for the delivery of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a performance period through November 29, 2024. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,894.80 firm fixed-price contract is for the supply of MITOSOL 0.2 MG KITS, a pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities worldwide. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $3,947.40 and is for the delivery of MITOSOL 0.2 MG KITS through April 3, 2024. The contract is part of DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This larger...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through January 15, 2025. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $26,316.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MITOSOL 0.2 MG KITS and has a ceiling value of $26,316.00 with a performance period ending on December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 contract is for the supply of 4566770837 MITOSOL 0.2 MG KITS, with a period of performance through December 12, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
  • SPE2DB25D9305
    Indefinite Delivery Contract
  • SPE2DB25D9305-SPE2DB25FQACK
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $3,947.40 and covers the delivery of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through February 21, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/1/25, 10:18 AM